Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.60
+0.18 (2.89%)
At close: Jun 26, 2026, 4:00 PM EDT
6.61
+0.01 (0.20%)
After-hours: Jun 26, 2026, 5:23 PM EDT
Eupraxia Pharmaceuticals Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Eupraxia Pharmaceuticals stock have an average target of 16.57, with a low estimate of 11 and a high estimate of 25. The average target predicts an increase of 151.25% from the current stock price of 6.60.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Eupraxia Pharmaceuticals stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 8 | 9 | 9 | 10 | 11 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 8 | 9 | 9 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $17 | Buy | Initiates | $17 | +157.77% | Jun 25, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $19 | Buy | Maintains | $19 | +188.10% | Jun 25, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Initiates $25 | Buy | Initiates | $25 | +279.08% | May 20, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $16 | Buy | Maintains | $16 | +142.61% | May 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $11 | Buy | Reiterates | $11 | +66.79% | May 14, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
9.90M
EPS This Year
-0.95
from -0.99
EPS Next Year
-0.88
from -0.95
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 89.1M | |
| Avg | n/a | 9.9M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 176.2% |
| Avg | - | -57.3% |
| Low | - | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.78 | 0.35 | |
| Avg | -0.95 | -0.88 | |
| Low | -1.13 | -1.39 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.